Ocular Therapeutix, Inc. (OCUL) Insider Trading
Over the last 3 months, OCUL insiders made 0 open-market buys and 5 sales, a net sale of -$360K (SEC Form 4). Over the last 6 months, 215 institutions increased and 126 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
5
Net (3m)
-$360.4K
Insider trades by month Buys Sells
Sep
Oct
Nov
Feb
May
Jun
Context3-month price +15.9%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 12, 2026 | Robins Jason Shandofficer: Chief Financial Officer | Grant | 14,024 | $8.74 |
| Jun 12, 2026 | Hong Seung Suhdirector | Grant | 44,000 | $8.74 |
| Jun 12, 2026 | LINDSTROM RICHARD L MDdirector | Grant | 14,000 | — |
| Jun 12, 2026 | Graves Adrienne Ldirector | Grant | 44,000 | $8.74 |
| Jun 12, 2026 | Graves Adrienne Ldirector | Grant | 14,000 | — |
| Jun 12, 2026 | Robins Jason Shandofficer: Chief Financial Officer | Grant | 15,441 | — |
| Jun 12, 2026 | Hong Seung Suhdirector | Grant | 14,000 | — |
| Jun 12, 2026 | Warden Charles Mdirector | Grant | 14,000 | — |
| Jun 12, 2026 | Warden Charles Mdirector | Grant | 44,000 | $8.74 |
| Jun 12, 2026 | RAINES MERILEEdirector | Grant | 44,000 | $8.74 |
| Jun 12, 2026 | Williams Leslie J.director | Grant | 14,000 | — |
| Jun 12, 2026 | RAINES MERILEEdirector | Grant | 14,000 | — |
| Jun 12, 2026 | LINDSTROM RICHARD L MDdirector | Grant | 44,000 | $8.74 |
| Jun 12, 2026 | Williams Leslie J.director | Grant | 44,000 | $8.74 |
| Jun 5, 2026 | Waheed Nadiaofficer: Chief Medical Officer | Sell | 14,828 | $8.27 |
| May 28, 2026 | Kaiser Peterofficer: Chief Development Officer | Sell | 2,967 | $8.20 |
| May 28, 2026 | Heier Jeffrey S.officer: Chief Scientific Officer | Sell | 3,018 | $8.20 |
| May 28, 2026 | Nayak Sanjayofficer: Chief Strategy Officer | Sell | 1,858 | $8.20 |
| May 28, 2026 | Dugel Pravindirector, officer: See Remarks | Sell | 21,156 | $8.20 |
| Feb 25, 2026 | Heier Jeffrey S.officer: Chief Scientific Officer | Sell | 3,057 | $8.28 |
| Feb 25, 2026 | Dugel Pravindirector, officer: See Remarks | Sell | 20,056 | $8.28 |
| Feb 25, 2026 | Nayak Sanjayofficer: Chief Strategy Officer | Sell | 1,759 | $8.28 |
| Feb 25, 2026 | Kaiser Peterofficer: Chief Development Officer | Sell | 2,810 | $8.28 |
| Feb 24, 2026 | Waheed Nadiaofficer: Chief Medical Officer | Sell | 3,510 | $7.74 |
| Feb 24, 2026 | LINDSTROM RICHARD L MDdirector | Buy | 60,229 | $7.66 |
| Feb 17, 2026 | Dugel Pravindirector, officer: See Remarks | Sell | 124,882 | $9.04 |
| Feb 17, 2026 | Waheed Nadiaofficer: Chief Medical Officer | Sell | 7,863 | $9.04 |
| Feb 17, 2026 | Notman Donaldofficer: Chief Operating Officer | Sell | 11,446 | $9.04 |
| Feb 17, 2026 | Nayak Sanjayofficer: Chief Strategy Officer | Sell | 10,348 | $9.04 |
| Feb 4, 2026 | Notman Donaldofficer: Chief Operating Officer | Sell | 5,455 | $9.14 |
Source: OCUL SEC Form 4 filings, latest Jun 12, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their OCUL positions over the last 6 months (SEC Form 13F).
Increased
215
New positions
133
Reduced
126
Sold out
72
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | Increased | 32.7M | May 15, 2026 |
| FMR LLC | Reduced | 31.8M | Feb 17, 2026 |
| DEEP TRACK CAPITAL, LP | Increased | 19.7M | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 17.4M | May 15, 2026 |
| BLACKROCK, INC. | Increased | 16.1M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 15.6M | Feb 12, 2026 |
| AVORO CAPITAL ADVISORS LLC | Reduced | 12.3M | May 15, 2026 |
| SUMMER ROAD LLC | Increased | 11.9M | Apr 23, 2026 |
| VANGUARD GROUP INC | Increased | 11.6M | Jan 29, 2026 |
| SUMMER ROAD LLC | Reduced | 11.1M | Feb 11, 2026 |
| AVORO CAPITAL ADVISORS LLC | Increased | 10.8M | Mar 16, 2026 |
| VR ADVISER, LLC | Increased | 10.3M | May 15, 2026 |
| DEEP TRACK CAPITAL, LP | Reduced | 8.1M | Feb 13, 2026 |
| VR ADVISER, LLC | Reduced | 7.3M | Feb 17, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 5.9M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.